Aqr Capital Management LLC Puma Biotechnology, Inc. Transaction History

Aqr Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$20.07 - $46.7 $600,313 - $1.4 Million	-29,911 Closed	0 $0
Q3 2018 Nov 15, 2018	SELL	$41.2 - $59.85 $614,374 - $892,483	-14,912 Reduced 33.27%	29,911 $1.37 Million
Q2 2018 Aug 14, 2018	BUY	$48.3 - $68.25 $45,933 - $64,905	951 Added 2.17%	44,823 $2.65 Million
Q1 2018 May 15, 2018	SELL	$59.7 - $99.25 $80,535 - $133,888	-1,349 Reduced 2.98%	43,872 $2.99 Million
Q4 2017 Feb 14, 2018	SELL	$93.85 - $132.45 $285,304 - $402,647	-3,040 Reduced 6.3%	45,221 $4.47 Million
Q3 2017 Nov 14, 2017	BUY	$72.0 - $119.75 $3.47 Million - $5.78 Million	48,261	48,261 $5.78 Million

102

29.1M

60.6K

16.3K

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $132M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aqr Capital Management LLC with notifications on news.